Infection was successfully mitigated by endocytosis inhibitors, such as Dyngo4a, but was not affected by TMPRSS2 inhibitors, supporting the conclusion that SARS-CoV-2 virus entered Mv1Lu cells mainly by endocytosis. Here, TMPRSS2 is linked to infection.